drugs Archives – Cambridge Enterprise

Polyproxin® molecules

PolyProx Therapeutics: a new class of drugs to halt difficult-to-drug cancers

27 February 2020

Seed Fund Investment Manager on BioBeat’s 2018 list of 50 Female Movers and Shakers

01 November 2018

Making medicine simple

04 October 2016

Cambridge University allies with TeraView to boost drug formulation

PhoreMost raises £2.5m to identify new targets for therapeutics

XO1 crystal structure

Spin-out X01 acquired by Janssen

DefiniGEN stem cell research plays vital role in developing new drugs

16 February 2015

Drugs

First of new generation of cancer drugs granted European approval

19 December 2014

Cambridge academics are winners in GSK’s Discovery Fast Track Challenge

01 December 2014

Lynparza recommended for approval in ovarian cancer

24 October 2014

Official opening of Cambridge labs at Stevenage Bioscience Catalyst

test tubes

Cambridge drug approved for treatment of multiple sclerosis

17 September 2013